Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Brunner

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Cardiovascular Research|November 15, 2011
The cardioprotective effects of parathyroid hormone are independent of endogenous granulocyte-colony stimulating factor releaseStefan Brunner, Tobias Weinberger, Bruno C Huber, et al.
Experimental Hematology|March 19, 2008
G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cellsStefan Brunner, Bruno C Huber, Rebekka Fischer, et al.
Molecular Imaging|September 25, 2014
In vivo monitoring of parathyroid hormone treatment after myocardial infarction in mice with [68Ga]annexin A5 and [18F]fluorodeoxyglucose positron emission tomographySebastian Lehner, Andrei Todica, Yordan Vanchev, et al.
High Altitude Medicine & Biology|November 4, 2020
Deceleration Capacity and Periodic Repolarization Dynamics As Predictors of Acute Mountain SicknessWolfgang Hamm, Sari Kassem, Lukas von Stülpnagel, et al.
Cardiovascular Research|December 7, 2007
Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survivalMarc-Michael Zaruba, Bruno C Huber, Stefan Brunner, et al.
European Heart Journal. Cardiovascular Imaging|October 1, 2015
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarctionLisa Gross, Lisa Paintmayer, Sebastian Lehner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 9, 2021
New challenges in cardiac intensive care unitsEnzo Lüsebrink, Antonia Kellnar, Clemens Scherer, et al.
Journal of Geriatric Cardiology : JGC|October 23, 2018
Age-dependent impact of the SYNTAX-score on longer-term mortality after percutaneous coronary intervention in an all-comer populationMadeleine Eickhoff, Stefanie Schüpke, Alexander Khandoga, et al.
Molecular Imaging|October 23, 2012
Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in miceSebastian Lehner, Andrei Todica, Stefan Brunner, et al.
European Heart Journal. Acute Cardiovascular Care|September 1, 2024
Do DanGer-SHOCK-like patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock? results of an individual patient data meta-analysisUwe Zeymer, Anne Freund, Matthias Hochadel, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Cardiovascular Research|November 15, 2011
The cardioprotective effects of parathyroid hormone are independent of endogenous granulocyte-colony stimulating factor releaseStefan Brunner, Tobias Weinberger, Bruno C Huber, et al.
Experimental Hematology|March 19, 2008
G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cellsStefan Brunner, Bruno C Huber, Rebekka Fischer, et al.
Molecular Imaging|September 25, 2014
In vivo monitoring of parathyroid hormone treatment after myocardial infarction in mice with [68Ga]annexin A5 and [18F]fluorodeoxyglucose positron emission tomographySebastian Lehner, Andrei Todica, Yordan Vanchev, et al.
High Altitude Medicine & Biology|November 4, 2020
Deceleration Capacity and Periodic Repolarization Dynamics As Predictors of Acute Mountain SicknessWolfgang Hamm, Sari Kassem, Lukas von Stülpnagel, et al.
Cardiovascular Research|December 7, 2007
Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survivalMarc-Michael Zaruba, Bruno C Huber, Stefan Brunner, et al.
European Heart Journal. Cardiovascular Imaging|October 1, 2015
FDG-PET reveals improved cardiac regeneration and attenuated adverse remodelling following Sitagliptin + G-CSF therapy after acute myocardial infarctionLisa Gross, Lisa Paintmayer, Sebastian Lehner, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 9, 2021
New challenges in cardiac intensive care unitsEnzo Lüsebrink, Antonia Kellnar, Clemens Scherer, et al.
Journal of Geriatric Cardiology : JGC|October 23, 2018
Age-dependent impact of the SYNTAX-score on longer-term mortality after percutaneous coronary intervention in an all-comer populationMadeleine Eickhoff, Stefanie Schüpke, Alexander Khandoga, et al.
Molecular Imaging|October 23, 2012
Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in miceSebastian Lehner, Andrei Todica, Stefan Brunner, et al.
European Heart Journal. Acute Cardiovascular Care|September 1, 2024
Do DanGer-SHOCK-like patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock? results of an individual patient data meta-analysisUwe Zeymer, Anne Freund, Matthias Hochadel, et al.
Pageof 13